NCT04868877 2026-02-19Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationMerus B.V.Phase 1/2 Active not recruiting194 enrolled